SCHEMBL22676499

SCHEMBL22676499

C=C(C)C(=O)Nc1ccc(-c2c(-c3ccc(C(=O)NC(O)CC)cc3)c3c(N)ncnc3n2C)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 3/20 0.54
▸ FGFR4 P22455 3/20 0.54
▸ FGFR2 P21802 2/20 0.54
▸ FGFR3 P22607 2/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CYP2D6 P10635 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ CYP2C19 P33261 1/20 0.54
▸ RET P07949 6/20 0.40
▸ BTK Q06187 7/20 0.39
▸ KDR P35968 3/20 0.36
▸ PIK3CD O00329 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ HCK P08631 1/20 0.36
▸ SRC P12931 1/20 0.36
▸ PIK3CA P42336 1/20 0.36
▸ PIK3CB P42338 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22678020 0.89 FGFR1 (0.55) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22676834 0.89 FGFR1 (0.54) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22676357 0.87 FGFR1 (0.54) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22676345 0.86 FGFR1 (0.55) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL25129255 0.86 FGFR1 (0.60) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22658549 0.86 FGFR1 (0.60) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL29407670 0.86 FGFR1 (0.60) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22676139 0.86 FGFR1 (0.51) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL22677999 0.86 FGFR1 (0.51) FGFR1FGFR4FGFR2FGFR3CYP3A4
SCHEMBL30303483 0.86 FGFR1 (0.51) FGFR1FGFR4FGFR2FGFR3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4306529-A2 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2024-01-17 — — EP disclosed
WO-2020231990-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2020-11-19 — — WO disclosed
Send feedback